FGFR1 and neoplasm: Among the rest, one tumor each had a ETV6-NTRK3 fusion, a PTEN deletion, an FGFR1 gain-of-function mutation, a CHEK2 LOF mutation (T367fs*), an AURKA-CSTF1 fusion, and a FANCA deletion.